Based on 9 analysts giving stock ratings to Beauty Health Co in the past month.
In the current month, SKIN has received 1 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. SKIN average Analyst price target in the last month is 0.992.
Based on analysts' estimates, SKIN EPS is projected to reach -0.064 in FY2026Q3, following reported EPS of -0.021 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.02, while Beauty Health CoSKIN's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.06.